AbCellera Biologics Inc.
ABCL
$4.39
$0.092.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 553.08M | 605.27M | 625.61M | 643.14M | 670.36M |
| Total Receivables | 153.37M | 126.61M | 92.13M | 63.24M | 67.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.70M | 8.10M | 8.63M | 11.51M | 8.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 742.15M | 764.98M | 751.37M | 742.88M | 771.55M |
|
|
|||||
| Total Current Assets | 742.15M | 764.98M | 751.37M | 742.88M | 771.55M |
| Net Property, Plant & Equipment | 424.02M | 347.10M | 340.43M | 331.26M | 318.88M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 40.26M | 41.19M | 42.11M | 52.58M | 85.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 57.45M | 61.56M | 96.54M | 134.22M | 80.21M |
| Total Assets | 1.40B | 1.34B | 1.36B | 1.39B | 1.41B |
|
|
|||||
| Total Accounts Payable | 32.04M | 32.80M | 34.35M | 34.80M | 26.59M |
| Total Accrued Expenses | 4.97M | 3.19M | 8.38M | 5.99M | 4.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.90M | 4.64M | 4.62M | 5.13M | 5.60M |
| Total Finance Division Other Current Liabilities | 25.12M | 34.77M | 29.27M | 33.66M | 33.84M |
| Total Other Current Liabilities | 25.12M | 34.77M | 29.27M | 33.66M | 33.84M |
| Total Current Liabilities | 67.02M | 75.40M | 76.61M | 79.57M | 70.38M |
|
|
|||||
| Total Current Liabilities | 67.02M | 75.40M | 76.61M | 79.57M | 70.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 137.18M | 63.21M | 60.74M | 66.27M | 66.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 190.78M | 182.62M | 167.11M | 168.89M | 164.68M |
| Total Liabilities | 394.99M | 321.23M | 304.47M | 314.73M | 301.51M |
|
|
|||||
| Common Stock & APIC | 973.15M | 958.67M | 943.53M | 928.19M | 910.79M |
| Retained Earnings | 36.58M | 71.31M | 116.93M | 151.14M | 202.25M |
| Treasury Stock & Other | -2.66M | -7.00M | -4.38M | -1.23M | -2.07M |
| Total Common Equity | 1.01B | 1.02B | 1.06B | 1.08B | 1.11B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.01B | 1.02B | 1.06B | 1.08B | 1.11B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.01B | 1.02B | 1.06B | 1.08B | 1.11B |
|
|
|||||